home / lobbying / lobbying_activities

lobbying_activities: 2598460

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
2598460 9c600bf7-58a9-4231-88e2-42fa5621aeb7 Q1 THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN 401103626 THE SUSAN G. KOMEN BREAST CANCER FOUNDATION, INC. DBA SUSAN G. KOMEN 2021 first_quarter INS S. 1067 - Access to Breast Cancer Diagnosis Act; bill to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging S. 1002 - Junk Plan Accountability Disclosure Act; bill to prohibit false or misleading advertising for health insurance coverage, require warnings and reporting with respect to noncomprehensive health plans, encourage enrollment in health plans, and for other purposes S. 464 - Safe Step Act; bill to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes S. 779 - Protecting Americans with Pre-Existing Conditions Act of 2021; bill to provide that certain rules and guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect. Comments to White House on clinical trial continuation, health disparities, federal research investment, funding for NBCCEDP, SSDI and Medicare waiting periods, access to diagnostic imaging, and telehealth. Efforts to reintroduce Cancer Drug Parity Act; bill to require health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. Implementation of the Affordable Care Act Public and private insurance adjustments and other policy changes due to the COVID-19 emergency, including those impacting the immunocompromised populations No Junk Plans Act; bill to overturn previous administration rule expanding non-comprehensive health insurance plans that dont have to provide health care coverage for people with pre-existing conditions Policies related to co-pay assistance programs Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,White House Office   70000 0 0 2021-04-16T16:11:16.727000-04:00
Powered by Datasette · Queries took 0.322ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API